Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Randomised Placebo Controlled Trial of Valganciclovir for Cytomegalovirus Viraemia in Adults and Adolescents With Advanced HIV Disease

NCT07379203 is registered in ClinicalTrials.gov with Wits Health Consortium (Pty) Ltd as lead sponsor.

NCT NCT07379203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Randomised Placebo Controlled Trial of Valganciclovir for Cytomegalovirus Viraemia in Adults and Adolescents With Advanced HIV Disease
Lead sponsor
Wits Health Consortium (Pty) Ltd
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
June 30, 2027
Enrollment
130 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus (cmv) infection